Objectives: 1. Describe the moiety of sulfonamide antibiotics that is associated with allergic responses 2. Recall the AAAI expert opinion on using sulfonamides in patients allergic to sulfonamide antibiotics

Objectives: 1. Describe the reason why aminopenicillins cannot be used for AmpC β-lactamase producing enterobacterales 2. Recall the dose of minocycline suggested by the IDSA for resistant gram-negative infections

Objectives: 1. Describe the IDSA recommendations for treating aspiration pneumonia 2. Recall the weaknesses of the studies that suggested anaerobes are involved in aspiration pneumonia

Objectives: 1. Describe the expert recommendations on what antiepileptic to avoid for toxin-related SE 2. Recall the effectiveness of traditionally recommended antiepileptics for toxin-related SE

Objectives: 1. Describe the patient characteristics that are desirable for using EN if the patient is on vasopressors 2. Recall the ASPEN and ESPEN recommendations for EN in a patient on vasopressors

Objectives: 1. Describe the updates to the ISTH guidance on the use of DOACs in obese patients 2. Recall which DOAC has the best evidence for use in obese patients

Objectives: 1. Describe where to find the most relevant recommendations for using epidurals and anticoagulants 2. Recall the medication classes without any special considerations according to ASRA

Objectives: 1. Describe the factors that raise the index of suspicion for legionella pneumonia 2. Recall the antibiotics used to treat legionella pneumonia

Objectives: 1. Describe the 4 stages of fluid use 2. Recall the two general ways a pharmacist can prevent the need for deresuscitation

Objectives: 1. Describe the factors that predict hypotension from propofol 2. Recall the incidence of awareness with paralysis in ED/ICU vs OR patients

Objectives: 1. Describe the potential weaknesses of CPOE systems relating to single doses of long acting medications 2. Recall what question to ask in order to build a mental picture of a patient prior to beginning order review

Objectives: 1. Describe level of evidence for phenobarbital in AWS 2. Recall the 2 general dosing strategies for phenobarbital in AWS